SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (1338)12/2/1997 10:30:00 PM
From: squetch  Read Replies (1) | Respond to of 4676
 
Miljenko, >>Knowing few chemical structures or small part of *old* biochemistry are not of any advantage in today biotechnology field<< With no science degree, are you saying I am better off. I have no burden of *old* biochemistry knowledge.(:>)

I thoughtI had read more abstracts in yeast from Whithead. Others will jump in for sure.

Jim McCamant has ISIP as a buy up to $20. All I can think is he must have SOME target price.($->) squetch


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News